EMS has proposed a merger with Hypera (HYPMY) in a deal that would create Brazil’s biggest pharmaceutical player, Pedro Arbex of Brazil Journal reports, citing people familiar with the matter. The transaction includes takeover bid would of R$30 per share, a premium of 17% compared to yesterday’s closing price and 39% to the current price, according to Arbex. A source involved in the operation told Brazil Journal that talks between the two companies about a potential merger have been going on for a long time.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.